Disruption of day-to-night changes in circadian gene expression with chronic tendinopathy

Ching-Yan Chloé Yeung1,2, René B Svensson1,2, Kateryna Yurchenko1,2

  • 1Institute of Sports Medicine Copenhagen, Department of Orthopedic Surgery, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

The Journal of Physiology
|February 22, 2023
PubMed

Insights

Human tendons exhibit time-dependent gene expression, indicating a circadian clock vital for collagen health. This circadian output is diminished in tendinopathy, suggesting new therapeutic targets for this common overuse injury.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Musculoskeletal Research

Background:

  • Tendinopathy is a significant clinical challenge with unknown causes.
  • Circadian clock genes are crucial for protein homeostasis and tendinopathy development in mice.
  • Human studies on tendon circadian rhythms are lacking, hindering therapeutic advancements.

Purpose of the Study:

  • To determine if human tendons possess a peripheral circadian clock.
  • To investigate circadian clock gene expression in healthy and tendinopathic human tendons.
  • To explore the role of circadian rhythms in collagen homeostasis in human tendons.

Main Methods:

  • RNA sequencing of human tendon biopsies taken 12 hours apart.
  • Collagen content and ultrastructural analyses.
  • Synchronized human tenocyte cultures to assess collagen gene expression.

Main Results:

  • Healthy tendons show time-dependent expression of 280 RNAs, including 11 circadian clock genes.
  • Tendinopathic tendons exhibit significantly fewer differentially expressed RNAs (23).
  • Collagen I (COL1A1, COL1A2) expression decreased at night but lacked circadian rhythmicity in tenocytes.

Conclusions:

  • Human patellar tendons possess a conserved circadian clock, evidenced by day-to-night gene expression changes.
  • A reduction in collagen I expression occurs at night in healthy tendons.
  • Reduced circadian output in tendinopathic tissues highlights the tendon circadian clock as a potential therapeutic target or biomarker.

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
102
Biological Clocks and Seasonal Responses02:45

Biological Clocks and Seasonal Responses

The circadian—or biological—clock is an intrinsic, timekeeping, molecular mechanism that allows plants to coordinate physiological activities over 24-hour cycles called circadian rhythms. Photoperiodism is a collective term for the biological responses of plants to variations in the relative lengths of dark and light periods. The period of light-exposure is called the photoperiod.
34.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K